User contributions for Nehal Eid

31 January 2025

• 19:0319:03, 31 January 2025 diff hist +3,816 N Olezarsen Created page with "{{DrugProjectFormSinglePage |authorTag=Nehal Eid |aOrAn=an |drugClass=Oligonucleotide |indicationType=treatment |indication=It is indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS). |adverseReactions=1-Injection site reactions 2-Decreased platelet count 3-Arthralgia |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color:#FF0000;">Condition Name:</span>''..." current

30 January 2025

• 18:0818:08, 30 January 2025 diff hist +13 Concizumab No edit summary current
• 18:0318:03, 30 January 2025 diff hist +2 Concizumab No edit summary
• 18:0218:02, 30 January 2025 diff hist +4,434 Concizumab No edit summary
• 17:2117:21, 30 January 2025 diff hist +1,590 Concizumab No edit summary
• 17:1017:10, 30 January 2025 diff hist +946 N Concizumab Created page with "{{DrugProjectFormSinglePage |authorTag=Nehal Eid |indicationType=treatment |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color:#FF0000;">Condition Name:</span>'' (Content) |offLabelAdultGuideSupport=There is limited information regarding ''Off-Label Guideline-Supported Use'' of Concizumab in adult patients. |offLabelAdultNoGuideSupport=There is limited information regarding ''Off-Label Non–Guideline-Supported..."